AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger

기사 요약

AstraZeneca in talks to merge with Bristol Myers Squibb, creating $400B pharma giant, while talks ongoing for months, antitrust scrutiny is expected.